Edwards Lifesciences Corp — Director's Dealing 2019

Oct 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2019-10-25

Reporting Person: Szyman Catherine M. (CVP, Critical Care)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-25	Common Stock	M	2500.0000	$66.8600	Acquired	19604.8134	Direct
2019-10-25	Common Stock	S	2500.0000	$227.1900	Disposed	17104.8134	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-25	Employee Stock Option (Right to Acquire)	$66.8600	M	2500.0000	Disposed	2022-02-18	Common Stock (2500.0000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2019.